247 related articles for article (PubMed ID: 32611447)
1. Excess Rab4 rescues synaptic and behavioral dysfunction caused by defective HTT-Rab4 axonal transport in Huntington's disease.
White JA; Krzystek TJ; Hoffmar-Glennon H; Thant C; Zimmerman K; Iacobucci G; Vail J; Thurston L; Rahman S; Gunawardena S
Acta Neuropathol Commun; 2020 Jul; 8(1):97. PubMed ID: 32611447
[TBL] [Abstract][Full Text] [Related]
2. Huntingtin differentially regulates the axonal transport of a sub-set of Rab-containing vesicles in vivo.
White JA; Anderson E; Zimmerman K; Zheng KH; Rouhani R; Gunawardena S
Hum Mol Genet; 2015 Dec; 24(25):7182-95. PubMed ID: 26450517
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic Huntington Alters BMP Signaling and Synaptic Growth through Local Disruptions of Endosomal Compartments.
Akbergenova Y; Littleton JT
J Neurosci; 2017 Mar; 37(12):3425-3439. PubMed ID: 28235896
[TBL] [Abstract][Full Text] [Related]
4. The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation.
Wong YC; Holzbaur EL
J Neurosci; 2014 Jan; 34(4):1293-305. PubMed ID: 24453320
[TBL] [Abstract][Full Text] [Related]
5. Huntingtin-mediated axonal transport requires arginine methylation by PRMT6.
Migazzi A; Scaramuzzino C; Anderson EN; Tripathy D; Hernández IH; Grant RA; Roccuzzo M; Tosatto L; Virlogeux A; Zuccato C; Caricasole A; Ratovitski T; Ross CA; Pandey UB; Lucas JJ; Saudou F; Pennuto M; Basso M
Cell Rep; 2021 Apr; 35(2):108980. PubMed ID: 33852844
[TBL] [Abstract][Full Text] [Related]
6. Excess active P13K rescues huntingtin-mediated neuronal cell death but has no effect on axonal transport defects.
Hansen T; Thant C; White JA; Banerjee R; Thuamsang B; Gunawardena S
Apoptosis; 2019 Apr; 24(3-4):341-358. PubMed ID: 30725352
[TBL] [Abstract][Full Text] [Related]
7. In-vivo evidence for the disruption of Rab11 vesicle transport by loss of huntingtin.
Power D; Srinivasan S; Gunawardena S
Neuroreport; 2012 Nov; 23(16):970-7. PubMed ID: 23032403
[TBL] [Abstract][Full Text] [Related]
8. Loss of huntingtin function slows synaptic vesicle endocytosis in striatal neurons from the htt
McAdam RL; Morton A; Gordon SL; Alterman JF; Khvorova A; Cousin MA; Smillie KJ
Neurobiol Dis; 2020 Feb; 134():104637. PubMed ID: 31614197
[TBL] [Abstract][Full Text] [Related]
9. Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease.
Reddy PH; Shirendeb UP
Biochim Biophys Acta; 2012 Feb; 1822(2):101-10. PubMed ID: 22080977
[TBL] [Abstract][Full Text] [Related]
10. Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease.
Shirendeb UP; Calkins MJ; Manczak M; Anekonda V; Dufour B; McBride JL; Mao P; Reddy PH
Hum Mol Genet; 2012 Jan; 21(2):406-20. PubMed ID: 21997870
[TBL] [Abstract][Full Text] [Related]
11. [Protein-Protein Interactions of Huntingtin in the Hippocampus].
Proskura AL; Vechkapova SO; Zapara TA; Ratushniak AS
Mol Biol (Mosk); 2017; 51(4):734-742. PubMed ID: 28900094
[TBL] [Abstract][Full Text] [Related]
12. Characterization of axonal transport defects in Drosophila Huntingtin mutants.
Weiss KR; Littleton JT
J Neurogenet; 2016; 30(3-4):212-221. PubMed ID: 27309588
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
Elife; 2021 Apr; 10():. PubMed ID: 33871358
[TBL] [Abstract][Full Text] [Related]
14. Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila.
Gunawardena S; Her LS; Brusch RG; Laymon RA; Niesman IR; Gordesky-Gold B; Sintasath L; Bonini NM; Goldstein LS
Neuron; 2003 Sep; 40(1):25-40. PubMed ID: 14527431
[TBL] [Abstract][Full Text] [Related]
15. Dendritic spine loss and neurodegeneration is rescued by Rab11 in models of Huntington's disease.
Richards P; Didszun C; Campesan S; Simpson A; Horley B; Young KW; Glynn P; Cain K; Kyriacou CP; Giorgini F; Nicotera P
Cell Death Differ; 2011 Feb; 18(2):191-200. PubMed ID: 21217767
[TBL] [Abstract][Full Text] [Related]
16. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.
Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I
Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655
[TBL] [Abstract][Full Text] [Related]
17. Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington's disease.
Yin X; Manczak M; Reddy PH
Hum Mol Genet; 2016 May; 25(9):1739-53. PubMed ID: 26908605
[TBL] [Abstract][Full Text] [Related]
18. A huntingtin peptide inhibits polyQ-huntingtin associated defects.
Arribat Y; Bonneaud N; Talmat-Amar Y; Layalle S; Parmentier ML; Maschat F
PLoS One; 2013; 8(7):e68775. PubMed ID: 23861941
[TBL] [Abstract][Full Text] [Related]
19. Effects of flanking sequences and cellular context on subcellular behavior and pathology of mutant HTT.
Chongtham A; Bornemann DJ; Barbaro BA; Lukacsovich T; Agrawal N; Syed A; Worthge S; Purcell J; Burke J; Chin TM; Marsh JL
Hum Mol Genet; 2020 Mar; 29(4):674-688. PubMed ID: 31943010
[TBL] [Abstract][Full Text] [Related]
20. Microglial physiological properties and interactions with synapses are altered at presymptomatic stages in a mouse model of Huntington's disease pathology.
Savage JC; St-Pierre MK; Carrier M; El Hajj H; Novak SW; Sanchez MG; Cicchetti F; Tremblay MÈ
J Neuroinflammation; 2020 Apr; 17(1):98. PubMed ID: 32241286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
